Weekly Influenza & Respiratory Illness Activity

Report
Week Ending Dec. 3, 2022 | WEEK 48
A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control.
All data are preliminary and may change as more information is received.

Minnesota Influenza Key Statistics

Contents
Percent of molecular laboratory tests positive 30.8%
Hospitalized Influenza Surveillance.............................................................................................................2
Hospitalizations 1,857
Influenza-Associated Death Surveillance....................................................................................................4
Most common strain Influenza A/H3 Respiratory Disease Outbreak Surveillance: School Outbreaks..................................................................5
Respiratory Disease Outbreak Surveillance: LTC Outbreaks.......................................................................6
School outbreaks 782 Sentinel Provider Surveillance (Outpatients)..............................................................................................7
Laboratory Surveillance ..............................................................................................................................8
Long-term care outbreaks 26
Minnesota Influenza Incidence Surveillance Project (MIISP) ...................................................................10
Pediatric influenza-associated deaths 0 Weekly U.S. Influenza Surveillance Report................................................................................................12

Minnesota Influenza Surveillance (www.health.state.mn.us/diseases/flu/stats/)

Weekly U.S. Influenza Surveillance Report (www.cdc.gov/flu/weekly/)
World Health Organization (WHO) Surveillance (www.who.int/influenza/surveillance_monitoring/updates/en/) Due to the COVID-19 pandemic, CDC and MDH will not
Neighboring states’ influenza information: be posting the weekly geographic spread indicators (no
activity, sporadic, local, regional, widespread) this season
Iowa: Iowa Flu Reports (idph.iowa.gov/influenza/reports)
as they rely on influenza-like illness data (ILI). Because
Wisconsin: Influenza (Flu) (www.dhs.wisconsin.gov/communicable/influenza/) these data are based on symptoms, the cause of ILI
North Dakota: Reported Seasonal Influenza Activity in North Dakota (www.ndflu.com/default.aspx) cannot reliably be attributed to influenza while COVID-19
South Dakota: South Dakota Influenza Information (doh.sd.gov/diseases/infectious/flu/) is widely circulating.

Minnesota Department of Health

651-201-5414 or 1-877-676-5414
www.health.state.mn.us
Week B (no genotype) B (Yamagata) B (Victoria) A (not subtyped) A H3 A H1 (unspecified) A (H1N1)pdm09 A (H1N2v) A (H3N2v) A&B Unknown Week 2017-2018 2018-2019 2019-202020 2021-2022 2022-2023

40

Type 1
4

4
1

3
Hospitalized Influenza Surveillance
1

2
40

41
3.0

4.0
2.0

5.0
0.0

1.0
2.0

0.0
3.0

9.0

42 11.0 6.0 1.0 3.0 Current year hospitalizations

Type 1 7 5 1

43 8.0 8.0 1.0 3.0 6.0

Hospitalized influenza cases are based on disease reports of laboratory-positive influenza (via DFA, IFA, viral culture, EIA, rapid test, paired serological tests
43 35 8 1

or RT-PCR) and specimens from hospitalized patients with acute respiratory illness submitted to MDH-PHL by hospitals and laboratories. Due to the need to
44 5.0 7.0 1.0 0.0 9.0
44 97 10 1

confirm reports and reporting delays, consider current week data preliminary.
45 39 2 1 45 7.0 12.0 2.0 2.0 10.0

45 1 229 12 1 46 2.0 22.0 3.0 2.0 42.0

Hospitalized Influenza Cases by Type, Hospitalized Influenza Cases by Season,

47 7.0 25.0 5.0 1.0 108.0
47 1 222 16 2

Minnesota (FluSurv-NET*) Minnesota (FluSurv-NET*)

48 10.0 51.0 1.0 12.0 243.0
48 3 273 73 6

49 13.0 46.0 1.0 28.0 241.0

49 1 423 72 5
1000
50 8.0 66.0 0.0 51.0 355.0

50
900 60018.0
51 110.0 0.0 105.0 501.0

51

800 52 50.0 194.0 2.0 129.0

52

1 50052.0 247.0 2.0 98.0

700
Number of hospitaliza�ons

Number of hospitaliza�ons
2 55.0 184.0 1.0 53.0

2 600
3 40051.0 203.0 4.0 35.0

3
500 4 99.0 237.0 0.0 23.0

400
5
300138.0 228.0 5.0 21.0

5
6 130.0 361.0 1.0 13.0

300
6 7
200155.0 372.0 1.0 19.0

7
200 8 228.0 446.0 0.0 8.0

8
100 9
100
193.0 422.0 1.0 22.0

9 0 10 257.0 368.0 1.0 20.0

40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
10
11 0236.0 244.0 0.0 26.0

MMWR Week 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
12 189.0 104.0 0.0 30.0
11
B (no genotype) A (not subtyped) A (H1N2v) Unknown MMWR Week
B (Yamagata) A H3 A (H3N2v) 13 186.0 34.0 0.0 21.0
12
B (Victoria) A (H1N1) pdm09 A&B
2022-2023 2021-2022 2020-2021 2019-2020 2018-2019 2017-2018
14 136.0 8.0 1.0 14.0
13

14
Hospitalizations this week Hospitalizations last week Total hospitalizations (to date) 15
Season 93.0 4.0
Total hospitalizations (historic)
0.0 25.0

15
501 559 1,857 16
2017-2018 51.0 3.0
6,446
0.0 36.0

16
17
2018-2019 55.0 2.0
2,543
0.0 35.0

18
2019-2020 28.0 0.0
4,022
0.0 34.0

17

19
2020-2021 28.0 1.0
35
0.0 21.0

18
20
2021-2022 16.0 0.0
901
0.0 7.0

19

*FluSurv-NET = Influenza Surveillance Network 2022-2023 (to date) 1,857 (to date)
20

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 2
 Hospitalized Influenza Surveillance (continued)
Number of Influenza Hospitalizations and Incidence by Region, Number of Influenza Hospitalizations and Incidence by Age,
Minnesota Minnesota

1500 150 1500 150

1400 140 1400 140
1300 130 1300 130
1200 120 1200 120
Age # of hospitalizations Incidence (cases) per
100,000 Persons

1100 110 1100 110

Hospitaliza�ons per 100,000 persons

Region # of hospitalizations Incidence (cases) per
100,000 Persons

1000 100 0-4

1000
207.0 59.8
100
Number of hospitaliza�ons

Number of hospitaliza�ons
Central

900
225.0 28.9

90 89.5
5-24
900
277.0 19.1
90

Incidence rate
Metro 1,327.0 42.4
800 80 25-49 800
251.0 13.8 80
Northeast
700
66.0 20.4
70 700 70
50-64 273.0 25.0

600 60 59.8
Northwest 17.0 10.7
600 60
65+ 849.0 89.5

500 50
South Central 47.0 16.1
42.4 500 50
Case Total 327 5.78
400 40
Southeast 109.0 21.3 400 40
300 30
28.9 21.3 300 30
Southwest 20.0 9.3

200 16.1 18.8 20

20.4 200 25.0 20
West Central 46.0 18.8

100 10 19.1
10.7 9.3 100 13.8 10
0 0
Total 327 5.80

0 0
Central Metro Northeast Northwest South Central Southeast Southwest West Central
0-4 5-24 25-49 50-64 65+

Region Age group (years)

Number of hospitaliza�ons Incidence (cases) per 100,000 persons Number of hospitaliza�ons Incidence (cases) per 100,000 persons

% Median age (years) at time of admission

Hospitalizations Total % Total
Region Hospitalizations
this week (to date) (to date) 62
this week
Central 96 225 19% 12%
Metro 286 1327 57% 71%
Northeast 24 66 5% 4%
Northwest 9 17 2% 1%
South Central 26 47 5% 3%
Southeast 34 109 7% 6%
Southwest 9 20 2% 1%
West Central 17 46 3% 2%

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 3
Week 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019 2017-2018

1.00

0.00
1

1
1.00

0.00
Influenza-Associated Death Surveillance
0.00

0.00
0.00

0.00
1.00

0.00
0.00

0.00

0.00 0.00 0.00 0.00 0.00 0.00

1.00 1 1.00 0.00 1.00 0.00 1.00

Influenza deaths are collected via reports from Minnesota’s death certificate database, hospitals, and long-term care facilities. Decedents with influenza listed
0.00 0 0.00 0.00 0.00 0.00 1.00

as a cause of or contributor to death, have recent laboratory confirmation of influenza, or are part of an ongoing influenza outbreak at a long-term care facility
are reported to influenza surveillance. Due to the need to confirm reports and reporting delays, consider current week data preliminary.
0.00 0 0.00 1.00 0.00 0.00 2.00

0.00 0 0.00 0.00 1.00 0.00 1.00

Deaths Associated with Influenza by Season, Deaths Associated with Influenza by Age Group and Season,
1.00 3 1.00 0.00 0.00 0.00 1.00

Minnesota Minnesota
0.00 2 0.00 0.00 1.00 1.00 3.00

2.00 3 2.00 0.00 1.00 1.00 8.00

0-17 18-49 50-64 65-79 80+
2.00
50 8 2.00 0.00 4.00 0.00 7.00
Season 2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023

2.00
45 4 2.00 0.00 3.00 3.00 23.00
250
0-17 6 1 3 0 2 0

6.00 6.00 0.00 3.00 3.00 25.00

40 18-49 10 9 15 2 5 1

6.00 6.00 3.00 10.00 2.00 48.00

50-64
200 37 16 31 1 6 4
35

Number of deaths
3.00 3.00 1.00 11.00 1.00 49.00
65-79 101 33 51 1 18 10
Number of deaths

9.00 30 9.00 0.00 4.00 3.00 50.00 150

80+ 281 36 53 3 23 13

1.00 1.00 1.00 8.00 3.00 42.00

25
5.00 5.00 1.00 8.00 4.00 35.00
100
20
3.00 3.00 0.00 9.00 6.00 27.00

15 50
3.00 3.00 0.00 12.00 8.00 17.00

0.00
10 0.00 0.00 15.00 8.00 33.00
0

2017-2018

2017-2018

2017-2018

2017-2018

2017-2018
2018-2019

2018-2019

2018-2019

2018-2019

2018-2019
2019-2020

2019-2020

2019-2020

2019-2020

2019-2020
2020-2021

2020-2021

2020-2021

2020-2021

2020-2021
2021-2022

2021-2022

2021-2022

2021-2022

2021-2022
2022-2023

2022-2023

2022-2023

2022-2023

2022-2023
0.00 0.00 0.00 23.00 3.00 16.00

5
0.00 0.00 0.00 20.00 18.00 5.00

0
1.00 1.00 0.00 21.00 15.00 12.00

40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Top: Age group (years)

Bo�om: Season
0.00 0.00 0.00
MMWR Week 15.00 14.00 6.00

2017-2018 2018-2019 2019-2020 2020-2021 2021-2022 2022-2023

1.00 2022-2023 2021-2022
1.00 2020-2021
0.00 2019-2020
13.00 2018-2019
5.00 2017-2018
5.00

1.00 1.00 0.00 4.00 8.00 12.00

Season Total deaths (historic) Total pediatric (<18 years) deaths (historic) Season Median age (years) at time of death
3.00 3.00 0.00 6.00 5.00 4.00

1.00
2017-2018 440 1.00 0.00
6 1.00 8.00 3.00
2017-2018 85

1.00
2018-2019 126 1.00 0.00
1 0.00 1.00 2.00
2018-2019 75

0.00
2019-2020 197 0.00 0.00
3 1.00 3.00 2.00
2019-2020 73

19
2020-2021 7 1.00 0.00
0 1.00 1.00 0.00
2020-2021 76

20
2021-2022 54 0.00 0.00
2 1.00 0.00 0.00
2021-2022 76.5
2022-2023 (to date) 28 0 2022-2023 (to date) 79
*FluSurv-NET = Influenza Surveillance Network

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 4
Week 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019

40

41
Respiratory Disease Outbreak Surveillance: School Outbreaks
1

9
8

8
0

0
1

3
1

1 2022-2033

42 7 1 1 1 0 1

43 2 0 4 0 9

K-12 schools report an outbreak of influenza-like illness (ILI) when the number of students absent with ILI reaches 5% of total enrollment or three or more
students with ILI are absent from the same elementary classroom.
44 6 0 0 2 7

45 6 1 4 4 18

46 10 1 4 4 97

47 1 0 19 1 195
Influenza-like Illness (ILI) in Schools by Season
48 9 0 7 1 240

300
49 11 0 14 5 142

280
50 26 0 61 5 76

260
51 22 0 172 6

52 0 0 240 5 0

53 31 0
220 9 0

200
1 30 0 32 12
Number of outbreaks

2 23 0 121 32

180
3 7 0 79 31

4 0 0
160 91 8

5 4 0 140 79 16

6 4 0
120 66 38

100
7 0 0 35 30

8 1 1 44 22

80
9 2 0 22 43

10 3 0
60 25 33

11 2 0 40 2 26

12 5 0
20 0 15

13 1 0 0 0 12

14 5 0
40 41 42 43 44 45 46 47 48 49 50 51 52
0 10
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

15 11 0 0 2
MMWR Week

16 5 0 0 5 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019

17 1 0 0 6

18 5 0 0 6
New school outbreaks this week New school outbreaks last week Total this season (to date)

19 6 1 0 4
76 142 782

20 6.0

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 5
Week 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019

0
Respiratory Disease Outbreak Surveillance: LTC Outbreaks
0

0
1

0
0

0
0

0
0

0 0 0 0 0 0

Long-Term Care (LTC) facilities report to MDH when they suspect an outbreak of influenza in their facility. Laboratory-confirmed outbreaks are reported here.
0 0 0 0 0 0

0 0 1 0 0 0

1 0 0 1 2 0

Confirmed Influenza Outbreaks in LTC by Season

0 1 1 0 0 1

1 2 1 0 1 0

0 2 1 1 1 0

20
1 3 1 0 2 0

2 7 3 0 0 0

18
1 12 5 0 2 0

2 7 0
16 0 1

3 7 1 6 0

3 5 0 14 6 0
Number of outbreaks

6 4 0 4 2

9 1 0
12 7 2

11 1 0 9 6

10
12 0 0 7 5

8
11 0 1 6 3

21 2 0 19 4

14 0 1 6 10 6

12 1 0 11 5

11 0 0
4 8 7

11 0 0 4 4

2
7 1 0 0 3

10 2 0 0 0 2

12 0 0
40 41 42 43 44 45 46 47 48 49 50 51 52
1 0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
6 1 0 0 2 MMWR Week
7 1 0 0 2 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019

1 0 0 0 2

3 0 0 0 1

3 0 0 0 1
New LTC outbreaks this week New LTC outbreaks last week Total this season (to date)
2
12 7 26

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 6
Week 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23

40

41
1.430

1.430
1.286

1.716
2.424

2.338
Sentinel Provider Surveillance (Outpatients)
0.660

0.870
4.710

4.010
1.650

1.79

42 1.420 1.396 2.211 0.730 3.750 1.870

43 1.240 1.539 2.395 0.500 4.020 1.640

MDH collaborates with healthcare providers who report the total number of patients seen and the total number of those patients presenting to outpatient
clinics with influenza-like illness.
44 1.370 2.247 2.409 0.550 4.160 1.790

45 1.420 1.758 2.277 0.700 4.210 1.860

Percentage of Persons Presenting to Outpatient Clinics with Influenza-Like Illness (ILI)

46 1.640 1.846 2.435 0.650 4.220 2.010

47 1.660 2.206 2.727 0.500 5.290 2.430

48 1.470 2.082 4.059 10%

0.420 4.350 3.400

49 2.150 1.899 3.530 0.330 4.450 4.300

9%
50 2.300 2.674 3.536 0.250 5.020 5.760

8%
51 2.940 2.580 5.651 0.140 6.060 4.870

52 3.640 3.401 9.711 0.130 6.640

53 4.230 3.270 3.700 7%

0.240 2.750
% of visits due to ILI

1 5.060 4.748 3.600 0.170 2.400

6%
2 5.810 3.214 3.300 0.180 2.060

3 6.320 3.795 3.900

5%
0.290 1.680

4 6.460 3.780 4.800 0.340 1.310

5 6.730 3.258 5.400 4%

0.230 1.290

6 5.690 3.463 6.400 0.300 1.210

3% Pre-pandemic MN Baseline: 2.8%

7 5.330 3.722 5.200 0.270 1.230

8 4.470 3.398 5.400

2%
0.350 1.290

9 3.760 3.592 5.200 0.270 1.390

10 2.980 3.560 4.400 1%

0.430 1.170

11 2.390 3.034 3.600

0%
0.340 1.230

12 2.330 2.286 2.300 0.350 40 41 42 43 44 45 46 47 48 49 50 51 52

1.230 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
13 1.660 2.415 2.200 0.360 1.340 MMWR Week

14 2.090 2.289 1.600 0.430 1.310 2018-19 2019-20 2020-21 2021-22 2022-23

15 2.180 2.149 1.300 0.420 1.420

* Indicates current week-data may be delayed by 1 or more weeks

‡ MN Baseline valid for 2020-21 season only, do not compare it with previous seasons. The baseline is
16 1.650 2.457 1.500 0.470 1.310

17
calculated by averaging the ILI percent for non-influenza weeks over the previous four seasons and
1.760 2.159 1.600 0.460 1.330

adding two standard deviations. Non-influenza weeks account for less than 2% of the season’s total % of outpatients with ILI this week % of outpatients with ILI last week
18
flu-positive specimens tested at Public Health Labs in HHS Region 5. Weeks where ILI % is above
1.680 1.893 1.900 0.440 1.310

baseline reflect weeks with excess health care visits due to ILI. 4.87% 6.11%
19 1.400 2.316 1.000 0.510 1.060

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 7
20
 Laboratory Surveillance
MMWR Week Flu % Positive 2022-34 Flu % Positive 2021-22 Flu % Positive 2020-21 Flu % Positive 2019-20 Flu B Flu A/H1 2009 Flu A/H3 Flu A/Unk

The MN Lab System (MLS) Laboratory Influenza Surveillance Program Specimens Positive for Influenza by Molecular Testing*, by Week
40 0.5 0.13 0.00 0.13 3 0 0 5

is made up of more than 310 clinic- and hospital-based laboratories,

41 2.1 0.10 0.60 0.34 2 0 0 69

voluntarily submitting testing data weekly. These laboratories perform

42 4.1 0.11 0.30 0.95 2 0 3 153 3000 100
rapid testing for influenza and Respiratory Syncytial Virus (RSV). 2800
90
Significantly fewer labs perform PCR testing for influenza and three also
43 7.9 0.10 0.00 2.03 1 5 6 319
2600

2400 80
perform PCR testing for other respiratory viruses. MDH-PHL provides
44 16.8 0.20 0.20 1.37 2 2 20 996

2200
further characterization of submitted influenza isolates to determine
45 24.9 0.09 0.00 3.33 6 0 11 1705
2000
70

the hemagglutinin serotype to indicate vaccine coverage. Tracking the

46 29.4 0.12 0.10 3.31 6 1 37 2091 1800 60

% Flu Posi�ve
Posi�ve tests
laboratory results assists healthcare providers with patient diagnosis of
47 35.4 0.38 0.10 8.59 22 1 37 2654
1600
50

influenza-like illness and provides an indicator of the progression of the 1400

48 30.8 2.46 0.00 9.92 7 1 41 2097
1200 40
influenza season as well as prevalence of disease in the community. 1000
49 8.09 0.10 11.69
30
800
50 12.40 0.03 17.36
600 20

51 16.80 0.10 25.33

400
10
200
52 13.93 0.10 28.80 0 0
40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 7.39 0.00 24.75
MMWR Week
Flu A/Unk Flu A/H3 Flu A/H1 2009 Flu B 2022-23 2021-22 2020-21 2019-20
2 6.12 0.09 23.82

3 4.56 0.00 29.19

4 3.36 0.16 28.53

5 3.00 0.06 31.34

6 3.31 0.00 33.03

7 3.35 0.07 35.96

Region % molecular influenza tests + this week
8 2.99 0.07 34.17
Central 36.1%
9 4.93 0.00 35.45 Metro 34.1%
10 3.40 0.18 27.71 Northeast 31.3%
11 5.10 0.00 22.09 Northwest 21.1%
12 3.60 0.12 9.28 South Central 36.0%
13 4.70 0.00 5.11 Southeast 36.2%
14 3.50 0.00 1.05 Southwest 26.8%
15 4.70 0.05 0.00 West Central 26.5%
16 5.20 0.00 0.00 Statewide (overall) 30.8%
17 5.20 0.00 0.00

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 8
18 5.10 0.00 0.00

19 3.20 0.00 0.00

Season 2021-2022 2020-2021 2019-2020 2018-2019 Pathogen Flu B Flu A/B Flu A Season 2021-2022 2020-2021 2019-2020 2018-2019 Pathogen
(RSVPercentPositive)

40

MMWR Week
5.0 0.00 0.00 1.03 0

Flu % Positive 2022-2023 Flu % Positive 2021-2022 Flu % Positive 2020-2021 Flu % Positive 2019-2020 Flu B
0

Flu A/B
Laboratory Surveillance (continued)
2

Flu A
MMWR Week

40
RSV% Positive 2022-2023 RSV% Positive 2021-2022 RSV% Positive 2020-2021 RSV% Positive 2019-2020 RSV

8.3 21.00 9.10 8.11 1

40
MLS Laboratories – Influenza Testing
5.0 0.00 0.00 1.03 0 0 2 41 36.4
MLS Laboratories – RSV Testing
36.00 10.00 6.25 16

41
Specimens Positive by Influenza Rapid Antigen Test, by Week
1.1 2.30 4.00 2.33 1 0 0 42
Specimens Positive by RSV Rapid Antigen Test, by Week
26.3 34.80 15.80 4.94 10

42 3.6 2.70 1.80 2.21 2 0 1 43 43.6 35.80 13.00 12.37 139

43
6005.5 0.60 1.20 1.80 4 1 11
100 44
30025.3 33.70 3.30 2.08 42
100

44 11.4 0.00 1.10 3.17 3 0 30

90 45 46.1 21.20 0.00 8.94 189
90

45 50021.1 0.38 3.20 4.69 11 1 105 46 25041.5 19.40 0.00 15.58 159

80 80
46 32.8 1.20 0.70 6.02 13 5 331 47 35.6 16.80 0.00 28.16 160

70 70
47
40043.0 1.79 3.40 9.54 10 1 462 48
20031.8 9.75 7.70 23.70 70

48 33.3 9.53 2.10 12.80 10 2 452 60 49 9.97 0.00 26.38

60
Posi�ve tests

Posi�ve tests
% Posi�ve

% Posi�ve
300 50
49 20.71 3.10 15.28 50 12.30 0.00 25.17

150 50
50 32.97 1.80 23.73 51 9.41 5.90 26.82

40
40
51 32.33 0.00 28.45 52 3.59 3.17 29.17
200
30 100
52 25.95 1.80 31.13 1 2.95 6.70 31.94 30

1 14.40 2.54 27.67 20 2 5.80 0.00 24.57

100 20
50
2 12.39 4.40 26.21 3 4.94 0.00 26.24
10
10
3 10.88 0.00 31.25 4 10.20 10.50 20.17
0 0
0 0
4 41 43
11.60 45 0.00 47 4933.08 51 1 3 5 7 9 11 13 15 17 19 5 3.80 0.00 22.83
41 43 45 47 49 51 1 3 5 7 9 11 13 15 17 19
MMWR Week
5 9.16 5.60 35.93 6 2.78 0.00 23.55
MMWR Week
Flu A Flu B Flu A/B 2022-2023 2020-2021
6 7.58 0.00 36.05 2021-2022 2019-2020 7 7.89 0.00 19.07
RSV 2022-2023 2020-2021
2021-2022 2019-2020
7 10.00 11.48 36.82 8 8.89 4.35 21.11

8 5.40 4.42 34.21 9 1.74 0.00 16.97

9
Region 7.74 4.66
% rapid antigen influenza tests + this week
35.05 10 Region 1.41 0.00 % rapid antigen RSV tests + this week
14.29

10
Central 6.80 0.00
26.2%
30.94 11 Central 2.00 0.00 38.8%
8.82

11
Metro 10.20 1.58
6.7%
22.61 12 Metro 2.00 0.00 9.1%
10.29

12
Northeast 4.10 2.18
33.3%
13.66 13 Northeast 0.73 0.00 42.1%
4.83

13
Northwest 7.80 3.18
37.3%
4.07 14
Northwest 2.90 0.00
25.0%
2.06

14
South Central 4.80 8.16
31.7%
1.88 15
South Central 2.32 3.33
23.5%
2.04

15
Southeast 4.40 2.44
38.7%
2.19 16
Southeast 2.44 0.00
32.6%
3.03

Southwest 29.6% Southwest 40.0%

16 2.60 0.00 1.35 17 2.30 7.69 2.63

West Central 40.0% West Central

17 3.40 3.50 1.04 18 1.40 0.00 18.18

Statewide (overall) 33.3% Statewide (overall) 31.8%

18 4.90 3.18 1.82 19 4.90 0.00

19 3.60 14.24 0.26 20 1.70 4.54

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 9
20 5.00 0.00 0.29
MMWR Week Adenovirus Metapneumovirus Seasonal Coronavirus Parainfluenza Virus 1-4 Rhinovirus RSV

40

41
1

6
0

0
0

0
0

8
19

57
29

396
Laboratory Surveillance (continued)
Some participants in the MN Lab System (MLS) Laboratory Influenza Surveillance Program also report testing data from respiratory virus panel PCR testing.
42 10 4 0 16 52 534

Tracking these laboratory results assists monitoring for non-influenza/non-COVID viruses that may be circulating and causing influenza-like illness.
43 9 0 2 7 46 748

44 9 2 0 27 86 871

45 8 2 1 14 42 796
Other Molecular Testing Results by Virus from MLS Survey
46 20
1500 0 5 25 72 905

1400
47 8 2 2 14 33 689

48 6 2 4 1 32 774

49
1300
50
1200
51

52
1100
1
1000
2

900
Posi�ve tests

4 800

700
5

7 600

500
8

10
400
11
300
12

13
200
14
100
15
0
16
40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
MMWR Week
17

18

RSV Rhinovirus Parainfluenza Virus 1-4 Seasonal Coronavirus Metapneumovirus Adenovirus

19

20

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 10
54Type1 65+ years 50-64 years 18-49 years 5-17 years 2-4 years 0-1 years

21

22
0

1
0

0
0

0
0

0
3

0
8

13
Hospitalized RSV Surveillance
Surveillance for respiratory syncytial virus (RSV) began in September 2016. Hospitalized inpatients of all ages who reside in the 7-county Twin Cities
23 1 0 1 0 4 8

metropolitan area (Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, and Washington) with laboratory-confirmed RSV are reportable. Due to the need to
24 0 0 0 0 2 16

confirm reports and reporting delays, consider current week data preliminary.
25 2 1 0 0 0 18

26
Hospitalized RSV Cases by Age, MinnesotaHospitalized RSV Cases by Age, Minnesota
1 0 0 0 1 6

200
27 3 0 0 0 1 8

28 1 1 0 0 2 3

180
29 0 0 0 0 4 11

30 0 1 0 0 0 8

31 0
160
0 0 0 3 12

32 0 0 0 0 3 4

33 1
140
0 0 0 1 7
Number of Hospitaliza�ons

34 1 0 0 0 1 10

35 0
120
0 0 1 0 15

36 1 1 0 0 4 13

37 1 100
0 6 3 6 24

38 0 0 1 2 12 29

39 1 80
2 0 2 7 47

40 1 1 2 6 16 43

41 4 60
2 2 11 21 82

42 4 2 4 9 38 87

43 8
40
5 3 15 27 135

44 11 6 3 12 43 107

45 16
20
6 9 11 33 119

46 19
07 2 7 29 91

47 22 4
22
3
24 3
26 12
28 78
30 32 34 36 38 40 42 44 46 48 50 52 2 4 6 8 10 12 14 16 18 20
48 18 5 2 7 27 59
MMWR Week
49

0-1 years 2-4 years 5-17 years 18-49 years 50-64 years 65+ years
50

51

52

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 11
 Weekly U.S. Influenza Surveillance Report
Week 47, ending Nov. 26, 2022
Seasonal influenza activity is high and continues to
increase across the country. Outpatient Illness: ILINet Activity Map
ƒ Of influenza A viruses detected and subtyped this
season, 79% have been influenza A(H3N2) and 21%
have been influenza A(H1N1).
ƒ Two influenza-associated pediatric deaths were
reported this week, for a total of 14 pediatric flu deaths
reported so far this season.
ƒ CDC estimates that, so far this season, there have been
at least 8.7 million illnesses, 78,000 hospitalizations,
and 4,500 deaths from flu.
ƒ The cumulative hospitalization rate in the FluSurv-NET
system is higher than the rate observed in week 47
during every previous season since 2010-2011.
ƒ The number of flu hospital admissions reported in the
HHS Protect system during week 47 almost doubled
compared with week 46.
ƒ The majority of influenza viruses tested are in the same
genetic subclade as and antigenically similar to the
influenza viruses included in this season’s influenza
vaccine.
ƒ All viruses collected and evaluated this season have
been susceptible to influenza antivirals.
ƒ An annual flu vaccine is the best way to protect against
flu. Vaccination helps prevent infection and can also
prevent serious outcomes in people who get vaccinated
but still get sick with flu.
ƒ CDC recommends that everyone ages 6 months and
older get a flu vaccine annually. Now is a good time to
get vaccinated if you haven’t already.
ƒ There are also prescription flu antiviral drugs that can be used to
treat flu illness; those need to be started as early as possible.

CDC National Influenza Surveillance (http://www.cdc.gov/flu/weekly/)

Minnesota Department of Health Weekly Influenza & Respiratory Activity Report for Week Ending Dec. 3, 2022 | WEEK 48 Page 12